Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-22

Clinical Trial Update: Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating glucomannan for abdominal pain-related functional gastrointestinal disorders in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucomannan (glucomannan)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Functional Gastrointestinal Disorders | Phase 4 | Status: COMPLETED